EUVIMEDEUVIMED entdecken
Crossref

Intratumoral microbiome profiles associated with immune tumor microenvironment and genetic alterations of colorectal cancer

A. Larano, V. Borisov, J. Schardey, R Yang, K. Tillmans, M. Illmer, J. Andrassy, J. Werner, F. Kühn, U. Wirth, C. K. Stein-Thoeringer

Zeitschrift für Gastroenterologie · 01.09.2024 · 62 (09) · e750

DOI: 10.1055/s-0044-1789944 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.09.2024. Verfasst von A. Larano und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Colorectal cancer (CRC) is a major public health problem with high morbidity and mortality rates. Increasing evidence suggests a dysbiosis of the gut microbiome in CRC patients as well as the presence of intratumoral microbes, which are hypothesized to influence cancer progression. However, we still don’t understand the mechanistic role of the intratumoral microbiome in CRC and whether it is involved in treatment resistance.

Aims

We aim (I) to investigate microbiome profiles and immune cell signatures as hallmarks of CRC microenvironment, and (II) to associate these features with tumor genetics and oncological outcomes in cancer patients.

Methods

Snap frozen primary CRC tissues (n=164) vs. adjacent healthy tissues (n=165) and metastasis tissues (n=20) from patients undergoing CRC surgery were retrieved from the LMU biobank. These specimens were utilized for 16S rRNA gene sequencing to analyze the intratumoral or mucosal microbiome and for RNA sequencing to study the tumor microenvironment. DADA2, phyloseq and EcoTyper were used for downstream bioinformatic analyses.

Results

First data analyses revealed different microbiome diversity states between healthy, primary tumor and metastases, or between tumor stages (I-IV). For instance, Bacteroides spp. were found more abundant in primary cancers. Early onset CRC vs. late-onset CRC was also associated with differences in microbiome diversity. KRAS mutated CRCs displayed lower diversity with an overrepresentation of Prevotella spp. compared to tumor with other cancers. Preliminary data also suggest microbiome diversity states to be predictive of cancer relapse. These results are currently replicated in an extended cohort of CRC patients, and amended by gene signature matrix analyses to infer immune cell states in the tumor microenvironment.

Conclusion

Collectively, we present first data that CRCs harbor a distinct microbial niche with a distinct immune cell signature and function that may promote cancer progression and relapse. Publication History Article published online: 26 September 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Larano, A., Borisov, V., Schardey, J., Yang, R., Tillmans, K., Illmer, M., Andrassy, J., Werner, J., Kühn, F., Wirth, U., & Stein-Thoeringer, C. K. (2024). Intratumoral microbiome profiles associated with immune tumor microenvironment and genetic alterations of colorectal cancer. Zeitschrift für Gastroenterologie, 62(09), e750. https://doi.org/10.1055/s-0044-1789944

Vancouver

Larano A, Borisov V, Schardey J, Yang R, Tillmans K, Illmer M, et al. Intratumoral microbiome profiles associated with immune tumor microenvironment and genetic alterations of colorectal cancer. Zeitschrift für Gastroenterologie. 2024;62(09):e750. doi:10.1055/s-0044-1789944

BibTeX
@article{Larano2024,
  author = {Larano, A. and Borisov, V. and Schardey, J. and Yang, R and Tillmans, K. and Illmer, M. and Andrassy, J. and Werner, J. and Kühn, F. and Wirth, U. and Stein-Thoeringer, C. K.},
  title = {Intratumoral microbiome profiles associated with immune tumor microenvironment and genetic alterations of colorectal cancer},
  journal = {Zeitschrift für Gastroenterologie},
  year = {2024},
  volume = {62},
  number = {09},
  pages = {e750},
  doi = {10.1055/s-0044-1789944}
}
Kostenlos starten →